Cargando…

Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 3 million patients globally. Previous data from Wuhan city showed that acute kidney injury (AKI), proteinuria and hematuria occurred frequently in patients with severe COVID-19. However, the prevalence of kidne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Daqing, Long, Lin, Wang, Amanda Y, Lei, Yu, Tang, Yun, Zhao, Jia Wei, Song, Xiaofei, He, Yanan, Wen, Ergang, Zheng, Ling, Li, Guisen, Wang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239220/ https://www.ncbi.nlm.nih.gov/pubmed/32695324 http://dx.doi.org/10.1093/ckj/sfaa083

Ejemplares similares

Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
por: Jeon, Jaehyun, et al.
Publicado: (2022)

The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019
por: Lupu, Lior, et al.
Publicado: (2023)

The current status of chronic kidney disease-mineral and bone disorder management in China
por: Zhan, Ya, et al.
Publicado: (2022)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
por: Tang, Wei, et al.
Publicado: (2020)

Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019
por: Gomi, Kuniyo, et al.
Publicado: (2021)

Clinical outcomes of mild to moderate coronavirus disease 2019 patients treated with Regdanvimab in delta-variant outbreak: Retrospective cohort study
por: Noh, Hyeong-Jun, et al.
Publicado: (2023)

Neurological manifestations in mild and moderate cases of COVID-19
por: Abdel Azim, Ghada Saed, et al.
Publicado: (2021)

Editorial: Manifestations of mild-to-moderate traumatic brain injury
por: Rauchman, Steven H., et al.
Publicado: (2023)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
por: Razonable, Raymund R, et al.
Publicado: (2022)

Clinical Characteristics and Risk Prediction Score in Patients With Mild-to-Moderate Coronavirus Disease 2019 in Japan
por: Marumo, Atsushi, et al.
Publicado: (2022)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Ocular manifestations of coronavirus disease 2019
por: Bostanci Ceran, Basak, et al.
Publicado: (2020)

The Neurologic Manifestations of Coronavirus Disease 2019
por: Elmashala, Amjad, et al.
Publicado: (2020)

Clinical Manifestations of Coronavirus Disease 2019
por: Kutsuna, Satoshi
Publicado: (2021)

CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity
por: Liu, Kai-Cai, et al.
Publicado: (2020)

Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019: A meta-analysis of randomized controlled trials
por: Fan, Zheng, et al.
Publicado: (2021)

Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial
por: Zheng, Jin-ping, et al.
Publicado: (2023)

Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort
por: Cheng, B., et al.
Publicado: (2020)

Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019
por: Singla, Vikas, et al.
Publicado: (2020)

2019 Novel Coronavirus Infection: Gastrointestinal Manifestations
por: Samanta, Jayanta, et al.
Publicado: (2020)

Coronavirus Disease-2019 Pneumonia: Clinical Manifestations
por: Sharifi, Husham, et al.
Publicado: (2023)

Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: a cross-sectional study
por: Peng, Lei, et al.
Publicado: (2022)

Kidney stones and moderate proteinuria as the rare manifestations of Gitelman syndrome
por: Chen, Qi, et al.
Publicado: (2021)

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
por: Kim, Ji-Won, et al.
Publicado: (2021)

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
por: Thilagar, Bright P., et al.
Publicado: (2022)

Correction to: A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
Publicado: (2023)

Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019
por: Elmunzer, B. Joseph, et al.
Publicado: (2021)

Metabolic Syndrome without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study
por: Hong, Daqing, et al.
Publicado: (2015)

Recognising the Gastrointestinal Manifestation of Pediatric Coronavirus Disease 2019
por: Bolia, Rishi, et al.
Publicado: (2020)

Neurological and Neuroradiological Manifestations in Neonates Born to Mothers With Coronavirus Disease 2019
por: Kurokawa, Mariko, et al.
Publicado: (2023)

Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019
por: Qian, Jing-Yi, et al.
Publicado: (2021)

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
por: Cen, Y., et al.
Publicado: (2020)

Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
por: Majeed, Abdulraheem Y., et al.
Publicado: (2023)

Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID‐19)
por: Kwok, Wang Chun, et al.
Publicado: (2022)

Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review
por: Ye, Zheng, et al.
Publicado: (2020)

Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
por: Ikeuchi, Kazuhiko, et al.
Publicado: (2020)

Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
por: Yan, Gabriel, et al.
Publicado: (2021)

Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study
por: Liu, Huaping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n1bs15lbiesif7uk19mk4l71m0